Robert Kirkman
2011 - Oncothyreon
In 2011, Robert Kirkman earned a total compensation of $1.1M as President, Chief Executive Officer and Director at Oncothyreon, a 39% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $192,035 |
---|---|
Option Awards | $484,000 |
Salary | $398,000 |
Other | $11,350 |
Total | $1,085,385 |
Kirkman received $484K in option awards, accounting for 45% of the total pay in 2011.
Kirkman also received $192K in non-equity incentive plan, $398K in salary and $11.4K in other compensation.
Rankings
In 2011, Robert Kirkman's compensation ranked 5,363rd out of 10,747 executives tracked by ExecPay. In other words, Kirkman earned more than 50.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,363 out of 10,747 | 50th |
Division Services | 803 out of 1,597 | 50th |
Major group Engineering, Accounting, Research, Management, And Related Services | 66 out of 172 | 62nd |
Industry group Research, Development, And Testing Services | 18 out of 45 | 60th |
Industry Commercial Physical and Biological Research | 18 out of 41 | 56th |
Source: SEC filing on April 24, 2014.
Kirkman's colleagues
We found five more compensation records of executives who worked with Robert Kirkman at Oncothyreon in 2011.